Bausch + Lomb: I Need To See Stability Before Upgrading This Name [Seeking Alpha]
Bausch + Lomb Corporation Common Shares (BLCO)
Company Research
Source: Seeking Alpha
BLCO's revenue grew across all segments in Q3 2025, driven by strong demand for dry eye products, MIEBO launch, and surgical consumables. Profitability remains volatile, with net income negative and cash flow metrics fluctuating, raising concerns about the reliability of future performance. Management targets 5%–7% annual revenue growth and EBITDA margin expansion to 23% by 2028, but current valuation appears fair relative to peers. Imgorthand/E+ via Getty Images Back in September of this year, I made the difficult decision to downgrade Bausch + Lomb ( BLCO ) from a "Buy" to a "Hold." The company looked mostly fairly valued at that moment, and I had been disappointed by some of its bottom-line performance. The More on my IG service Crude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential. Subscribers get to use a 5
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation Common Shares news events
Weekly update
A roundup of the hottest topics
BLCO
News
- How Bausch + Lomb's $2.8 Billion Refi and Eye-Care Pipeline Momentum Will Impact Bausch + Lomb (BLCO) Investors [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Announces Refinancing of Outstanding Term B Loans [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Announces Refinancing of Outstanding Term B LoansBusiness Wire
- Why Bausch + Lomb (BLCO) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb (NYSE:BLCO) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.MarketBeat
BLCO
Earnings
- 10/29/25 - Beat
BLCO
Sec Filings
- 12/12/25 - Form 8-K
- 11/18/25 - Form 4
- 11/18/25 - Form 4
- BLCO's page on the SEC website